Nitroglycerin (Ointment): Low Bone Density or Osteoporosis in Postmenopausal Women

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Pacts, a quarterly publication available from Wolters Kluwer Health. Off-Label Drug Pacts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@kumc.edu.

Get full access to this article

View all access options for this article.

References

Qaseem A, Snow V, Shekelle P, Hopkins R, Forcia MA, Owens DK; for the Clinical Efficacy Assessment Subcomittee of the American College of Physicians. Pharmacological treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008; 149: 404–415.

Kholsa

Is nitroglycerin a novel and inexpensive treatment of osteoporosis?

JAMA. 2011; 305(8): 826–827.

Papaioannou

Morin

Cheung

A.M.

; for the Scientific Advisory Council of Osteoporosis Canada. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. Can Med Assoc J. 2010; 182(17): 1864–1873.

North American Menopause Society. Management of osteoporosis in postmenopausal women: 2010 position statement of the North American Menopause Society. Menopause. 2010; 17(1): 25–54.

Wimalawansa

S.J.

Nitroglycerin therapy is as efficacious as standard estrogen replacement therapy (Premarin) in prevention of oophorectomy-induced bone loss: a human pilot clinical study. J Bone Mineral Res. 2000; 15(11): 2240–2244.

Wimalawansa

S.J.

Grimes

J.P.

Wilson

A.C.

Hoover

D.R.

Transdermal nitroglycerin therapy may not prevent early postmenopausal bone loss. J Clin Endocrinol Metabol. 2009; 94: 3356–3364.

Jamal

S.A.

Browner

W.S.

Bauer

D.C.

Cummings

S.R.

Intermittent use of nitrates increases bone mineral density: The Study of Osteoporotic Fractures. J Bone Mineral Res. 1998; 13(11): 1755–1759.

Jamal

S.A.

Goltzman

Hanley

D.A.

Papaioannou

Prior

J.C.

Josse

R.G.

Nitrate use and changes in bone mineral density: the Canadian Multicentre Osteoporosis Study. Osteoporos Int. 2009; 20: 737–744.

Jamal

S.A.

Hamilton

C.J.

Eastell

Cummings

S.R.

Effect of nitroglycerin ointment on bone density and strength in postmenopausal women. A randomized trial. JAMA. 2011; 305(8): 800–807.